NHLBI Progenitor Cell Translational Consortium (U01)

Funding Opportunity RFA-HL-16-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement requests applications to participate in the NHLBI Progenitor Cell Translational Consortium (PCTC). The goal of the Consortium is to translate advances in progenitor cell biology towards application to heart, lung, and blood diseases. The initiative will focus on the use of progenitor cell-based disease models to understand disease mechanisms, the development of novel therapies, and the application of cell-based therapies for the treatment of diseases.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding